Bluebird bio stock surges after FDA lifts clinical hold on studies for sickle cell disease treatmentsMarket Watch • 06/07/21
bluebird bio Announces the Lifting of FDA Clinical Hold for Sickle Cell Disease and β-Thalassemia StudiesBusiness Wire • 06/07/21
bluebird bio, Inc. Reports Inducement Grants to CCO Tom Klima Under Nasdaq Listing Rule 5635(c)(4)Business Wire • 06/02/21
bluebird bio Receives Positive CHMP Opinion for SKYSONA™ (elivaldogene autotemcel, Lenti-D™) Gene Therapy for Patients Less Than 18 Years of Age with Early Cerebral Adrenoleukodystrophy (CALD)Business Wire • 05/21/21
bluebird bio to Present Data from Its Severe Genetic Disease and Oncology Portfolios During the EHA2021 Virtual CongressBusiness Wire • 05/13/21
bluebird bio Reports First Quarter Financial Results and Highlights Operational ProgressBusiness Wire • 05/05/21
Bluebird Bio (BLUE) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseZacks Investment Research • 05/03/21
bluebird bio Provides Update on Severe Genetic Disease Programs and Business OperationsBusiness Wire • 04/20/21
PsiOxus and bluebird bio Present Novel Data Combining PsiOxus T-SIGn Platform with CAR-T Therapy to Clear Primary Tumors and MetastasesBusiness Wire • 04/14/21
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of bluebird bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 13, 2021 - BLUENewsfile Corp • 04/13/21
DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 04/13/21
Final Deadline Today: Rosen, National Trial Counsel, Encourages bluebird bio, Inc. Investors with Losses to Secure Counsel Before Important April 13 Deadline in Securities Class Action - BLUENewsfile Corp • 04/13/21
BLUE Final Deadline Today: Bronstein, Gewirtz & Grossman, LLC Reminds bluebird bio, Inc. Investors of Class Action and Lead Plaintiff Deadline April 13, 2021Newsfile Corp • 04/13/21
BLUE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 13, 2021 in the Class Action Filed on Behalf of bluebird bio, Inc. Limited ShareholdersNewsfile Corp • 04/12/21
DEADLINE TUESDAY ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmPRNewsWire • 04/12/21
BLUE INVESTOR FILING DEADLINE TOMORROW : Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Has Been Filed Against bluebird bio, Inc.PRNewsWire • 04/12/21